CNXC vs G
As of Sep 20, 2026, Concentrix (CNXC) scores 3.8/10 and Genpact (G) 5.4/10 on AlphaStocks' five-model composite, so G scores higher.
CNXC
Concentrix Corp
3.8
Weak
$27.89
G
Genpact LTD
5.4
Consider Buy
$34.10
CNXC vs G: Which is the Better Investment?
Concentrix Corp (CNXC) scores 3.8/10 while Genpact LTD (G) scores 5.4/10 on AlphaStocks' composite model. Genpact LTD has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | CNXC | G |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 3.8/10 | 5.4/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $27.89 | $34.10 |
| P/E Ratio | — | 10.9 |
| ROE | -31.5% | 21.7%▲ |
| Market Cap | $2B | $6B |
| Fair Value | — | — |
| Dividend Yield | 6.8%▲ | 2.3% |
| Sector Rank | #196 of 265 | #83 of 265▲ |
| Model Verdicts | ||
| Piotroski | Neutral | Attractive▲ |
| Buffett | Caution | Strong▲ |
| Graham | Neutral | Neutral |
| Lynch | Neutral | Attractive▲ |
| Greenblatt | Caution | Strong▲ |
Related comparisons
CNXC vs G: Which Stock Scores Higher?
Concentrix Corp (CNXC) and Genpact LTD (G) are both in the Industrials sector. G currently leads with a composite score of 5.4/10 (Consider Buy) compared to CNXC's 3.8/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer